Stryker Corp (SYK) stock
Close on Nov 12, 2026Market cap $118.92BP/E 33.3Yield –
Stryker Corp grew revenue 7.9% to $26.30B over the twelve months to Sep 30, 2026. Operating income rose 48.2% to $5.43B, moving the operating margin from 15.0% to 20.7%. Free cash flow was $4.57B, up 12.3% from a year earlier. At the latest close the market valued the company at $118.92B, 33.3 times its earnings.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2026
Valuation
- Market cap
- $118.92B
- P/E ratio
- 33.3
- Price to sales
- 4.52
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- 3.85%
Fundamentals
- Revenue
- $26.30B
- Net income
- $3.62B
- EPS, diluted
- $9.39
- Free cash flow
- $4.57B
- Diluted shares
- 385M
Trading
- Next earnings
- Jan 28, 2027 (estimated, after the close)
- Previous close
- $318.79
- Open
- $321.42
- Day's range
- $311.81 – $323.61
- Volume
- 2,435,500
- Average volume (20 days)
- 3,235,305
- Index membership
- S&P 500, Russell 1000, Russell 3000
- Beta (5 years)
- 0.81
- 52-week range
- $267.00 – $389.33
- RSI (14 days)
- 52.6
- Volatility (1 year)
- 32.7%
- Relative volume
- 0.89×
- WACC
- 8.4%
Index membership is inferred from the holdings of funds that track each index (VOO, IVV, SPYM, IWB, IWV), as reported to the SEC for Jun 30, 2026. Join dates come from quarterly fund reports since 2019, so they are accurate to the quarter.
Market cap history
Month-end market cap since 2009, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.
| Period | SYK | S&P 500 | Difference | SYK per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +10.5% | -2.7% | +13.2 pts | ||
| 3 months | -9.7% | -1.7% | −8.0 pts | ||
| Year to date | -10.4% | +11.9% | −22.3 pts | ||
| 1 year | -14.0% | +12.0% | −26.0 pts | ||
| 3 years | +17.6% | +78.2% | −60.6 pts | +5.6% | +21.2% |
| 5 years | +24.6% | +73.2% | −48.7 pts | +4.5% | +11.6% |
| 10 years | +216.1% | +309.6% | −93.5 pts | +12.2% | +15.1% |
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Stryker filed with the SEC as exhibits to Form 8-K or 6-K
- Update
- Results
- Update
- Update
- Update
- Results
About Stryker
Surgical & Medical Instruments & Apparatus
Stryker Corporation operates primarily across two operating segments: MedSurg and Neurotechnology, and Orthopaedics and Spine. Its main offerings encompass surgical instruments, endoscopy equipment, medical devices, neurovascular technologies, and neurocranial solutions, as well as knees, hips, spine, and trauma and extremities products. The company also provides customer lease agreements. Stryker serves healthcare organizations, surgeons, hospitals, and clinical specialists.
Company profile, executives and historyStryker stock: common questions
What is Stryker's stock price?
SYK closed at $312.39 on Nov 12, 2026, down 2.01% on the day. Over the past 52 weeks it traded between $267.00 and $389.33.
What is Stryker's market cap?
Stryker was worth $118.92B at the close on Nov 12, 2026: the share price times the diluted shares outstanding.
What is SYK's P/E ratio?
SYK trades at 33.3 times earnings, based on diluted earnings per share of $9.39 over the twelve months to Sep 30, 2026.
How much revenue does Stryker make?
Stryker reported revenue of $26.30B for the twelve months to Sep 30, 2026, up 7.9% from a year earlier.
Does Stryker pay a dividend?
No. Stryker has not paid a cash dividend over the last twelve months.
When does Stryker report earnings next?
Stryker is expected to report Q4 FY2026 results on Jan 28, 2027, after the close. The date is estimated from its past reporting pattern until the company confirms it.
How has SYK stock performed over the past year?
Including dividends, SYK returned -14.0% over the past year, against +12.0% for the S&P 500.
How many SYK shares are sold short?
7M shares were sold short at the latest FINRA report, 1.83% of the float, or 2.2 days of average trading volume.
Who are Stryker's competitors?
Companies most similar to Stryker by business, industry and size include BSX, BDX, BAX, MDLN, MMM.
See a number that looks wrong?